"objectiveId": "393044533027278848",
Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
。heLLoword翻译官方下载是该领域的重要参考
"What [Squire's team] do day in and day out, and what they see, is a magnification of hundreds of times of what I've seen or had to deal with."
return re.sub(r"\s+", " ", node.get_text(" ", strip=True)).strip()